If that’s left you feeling a little confused, fear not. As we near the end of 2025, our writers have taken a look back over the AI terms that dominated the year, for better or worse. Make sure you ...

Meta shares are showing early signs of technical stress after failing to extend recent highs, with price pulling back toward ...

Meta finds itself navigating starkly contrasting legal landscapes. While a major US antitrust case has concluded in the company's favor, a decisive legal blo ...

A new systematic review and meta-analysis indicates that engaging with short-form videos on platforms like TikTok, Instagram ...

Lowering systolic blood pressure is linked to a similar reduction in the risk for major cardiovascular events in people with ...

Traditional semantic layers often rely on middle-tier caching, introducing additional latency and cost. MetaKarta Semantic Hub takes a different approach through orchestrated materialization, ...

Unprecedented AI developments dominated this year, as investors poured millions into both AI-powered and human-centric tools ...

Meta Platforms' Family of Apps segment delivers robust profitability, with net profit margin above 30% and ROIC exceeding 23%. Read why META stock is a Buy.

Plaintiffs allege Meta hid product risks from users and authorities Meta accused of ineffective youth safety features and prioritizing growth over safety Meta opposed unsealing of internal documents ...

Meta’s acquisitions of Instagram and WhatsApp did not illegally stifle competition in social networking, a judge found, a major win for the tech giant. Meta has defended itself by saying that it faces ...

Meta scored a major win on Tuesday after a federal judge ruled that it is not a social networking monopoly, shooting down an argument from the US Federal Trade Commission that it should be forced to ...

Meta internally projected late last year that it would earn about 10% of its overall annual revenue – or $16 billion – from running advertising for scams and banned goods, internal company documents ...